180 Life Sciences Corp.’s recent filing unveils that its Director STEINMAN LAWRENCE acquired Company’s shares for reported $22068.0 on Jun 01. In the deal valued at $1.23 per share,18,000 shares were bought. As a result of this transaction, STEINMAN LAWRENCE now holds 48,129 shares worth roughly $ 32246.43.
Then, McGovern Jr. Donald A. bought 10,000 shares, generating $11,470 in total proceeds. Upon buying the shares at $1.15, the Director now owns 30,099 shares.
Before that, McGovern Jr. Donald A. bought 5,000 shares. 180 Life Sciences Corp. shares valued at $5,800 were divested by the Director at a price of $1.16 per share. As a result of the transaction, McGovern Jr. Donald A. now holds 20,099 shares, worth roughly $13466.33.
Maxim Group initiated its 180 Life Sciences Corp. [ATNF] rating to a Buy in a research note published on Friday, September 15, 2021; the price target was $11. PT values the company’s stock at a premium of 93.91 to its Friday closing price.
Price Performance Review of ATNF
On Friday, 180 Life Sciences Corp. [NASDAQ:ATNF] saw its stock jump 0.54% to $0.67. On the same session, the stock had its day’s lowest price of $0.64, but rose to a high of $0.695. Over the last five days, the stock has gained 19.96%. 180 Life Sciences Corp. shares have fallen nearly -80.22% since the year began. Nevertheless, the stocks have fallen -96.06% over the past one year. While a 52-week high of $18.66 was reached on 01/05/23, a 52-week low of $0.54 was recorded on 08/28/23. SMA at 50 days reached $0.8931, while 200 days put it at $2.4659. A total of 0.15 million shares were traded, compared to the trading of 0.15 million shares in the previous session.
Levels Of Support And Resistance For ATNF Stock
The 24-hour chart illustrates a support level at 0.6421, which if violated will result in even more drops to 0.6135. On the upside, there is a resistance level at 0.6971. A further resistance level may holdings at 0.7235. The Relative Strength Index (RSI) on the 14-day chart is 42.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0313, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 34.04%. Stochastics %K at 59.62% indicates the stock is a holding.
How much short interest is there in 180 Life Sciences Corp.?
A steep rise in short interest was recorded in 180 Life Sciences Corp. stocks on Aug 14, 2023, growing by 0.6 million shares to a total of 0.63 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 30150.0 shares. There was a rise of 95.23%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 10.97% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.86.
180 Life Sciences Corp. [ATNF] – Who Are The Largest Shareholders?
In filings from Renaissance Technologies LLC, it is revealed that the company now owns 119,995 shares, or roughly 2.26% of the outstanding ATNF shares. In other words, the investor’s shares have risen by 5,259 from its previous 13-F filing of 114736.0.. At present, BlackRock Financial Management, I is holding 418 shares valued at $393.0. Morgan Stanley Smith Barney LLC owned 316 shares of the company at the time of its most recent 13F filing, worth $297.0.
According to FactSet, 180 Life Sciences Corp.’s share price will average $4.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 497.01 percent from its previous closing price of $0.67. Analysts expect 180 Life Sciences Corp. stock to reach the higher price of $4.00, while the lowest price estimate is $4.00. However, 1 analyst have rated ATNF stock as a Buy in their predictions for 2023.